| 发明名称 |
METHODS FOR ASSESSING ENDOMETRIAL RECEPTIVITY OF A PATIENT AFTER CONTROLLED OVARIAN HYPERSTIMULATION |
| 摘要 |
The present invention relates to methods and kits for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation. More particularly, the invention relates to a method for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation, comprising a step consisting of measuring the expression level of at least one gene selected from fifteen genes in an endometrial biopsy sample obtained from said patient wherein said genes are FGFBP1, MUC20, TM-PRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP, and FOXP1. |
| 申请公布号 |
US2014371092(A1) |
申请公布日期 |
2014.12.18 |
| 申请号 |
US201214352768 |
申请日期 |
2012.10.22 |
| 申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE ;UNIVERSITE DE MONTPELLIER 1 ;Centre Hospitalier Universitaire de Montpellier |
发明人 |
Hamamah Samir;Haouzi Delphine |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation, comprising a step of
measuring an expression level of at least one gene selected from fifteen genes in an endometrial biopsy sample obtained from said patient wherein said fifteen genes are FGFBP1, MUC20, TMPRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP, and FOXP1. |
| 地址 |
Paris FR |
